IP Library › Assignment 028893/0986
Patent Assignment
Reel/Frame 028893/0986

Merger

Recorded: 2012-09-04 Pages: 5
Assignor
ADNEXUS THERAPEUTICS, INC.
Executed: 2007-10-19
Assignee
ADNEXUS, A BMS R&D COMPANY
RT. 206 & PROVINCE LINE ROAD, PRINCETON, NEW JERSEY, 08543-4000
Covered Property (1)
Methods of Inhibiting Type 2 Vascular Endothelial Growth Factor Receptors Using Polypeptides
Patent: 8,609,613 →
Application: 13/552,398 →
Publication: US 2012/0283184
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 4, 2012
From: ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 028894/0059 →
Assignment of Assignor's Interest Sep 4, 2012
From: CHEN, YAN; GETMANOVA, ELENA; WRIGHT, MARTIN C.; HARRIS, ALAN S.
To: ADNEXUS THERAPEUTICS, INC.
Reel/Frame 028904/0262 →
Change of Name Sep 4, 2012
From: ADNEXUS, A BMS R&D COMPANY
To: ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
Reel/Frame 028904/0275 →